Prospective registry study shows no increase in birth defects ...

Dupilumab demonstrated long-term efficacy and safety among pediatric patients aged 6 months and older with atopic dermatitis.

A large real-world study of Medicare beneficiaries found mepolizumab matched dupilumab for preventing asthma hospitalizations ...

Real-world retrospective data presented at FC26 indicate early dupilumab treatment significantly reduces the cumulative ...

Smoking is not only a key risk factor for COPD, but it can also impact the efficacy of other COPD medicines, such as inhaled corticosteroids. So it is important to understand h ...

Real-world data at the 2026 Fall Clinical Dermatology Conference show dupilumab in children with atopic dermatitis cuts new ...

Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell ...

Treatment of eosinophilic esophagitis (EoE) in adults with the monoclonal antibody dupilumab, already approved for treatment of the condition, significantly improved esophageal diameter over 24 weeks ...

A new case series and literature review suggest the interleukin-4 and interleukin-13 blocker dupilumab may bring relief to ...

Please provide your email address to receive an email when new articles are posted on . Incidence rates for cancers included 12.88 for the exposed group and 15.04 for the unexposed group. Adjusting ...